University of Rochester
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Rochester sits in the top decile of US sponsors by registered trial count (#53 of 15,742 sponsors by registered trial count).
University of Rochester: 636 sponsored US clinical trials, 94 recruiting.
University of Rochester sponsors 636 registered US clinical trials on ClinicalTrials.gov, 94 of them currently recruiting, and 448 completed. 54 of these trials are in Phase 3-4 (later-stage) and 147 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Cancer, with 7 trials.
Top-decile sponsor footprint
University of Rochester ranks in the top decile of sponsors by registered trial count (#53 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
448 of 506 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
636 total, page 3 of 13
Decreasing Polypharmacy in Older Adults With Curable Cancers Trial
NCT05046171
Tolerability and Activity of Brivaracetam (BRV) in Patients With Diffuse Gliomas
NCT05029960
Community Outreach for Palliative Engagement -- Parkinson Disease
NCT05222386
Factors Associated With Response to Cardiac Resynchronization Therapy in Heart Failure Patients With Non-LBBB ECG Pattern
NCT06977217
Insertable Cardiac Monitor-Guided Early Intervention to Reduce Atrial Fibrillation Burden Following Catheter Ablation
NCT04922281
Comparing Virtual Yoga to Standard Care on Insomnia Among Cancer Survivors
NCT04458194
A Study of Polatuzumab Vedotin, Rituximab and Dose Attenuated CHP in Older Patients With DLBCL
NCT04594798
Re-thinking the Role of Peers And Training Patients [RePeAT]
NCT05933655
Steroid Sparing Treatment With in Newly Diagnosed Transplant Ineligible Patients With Multiple Myeloma
NCT04635189
Visual Rehabilitation After Occipital Stroke
NCT04798924
Network Intervention to Prevent Vaping
NCT04678245
A-SPIRE Heart Failure: Utilizing Health Tags to Identify Patients at Risk for Hospital Readmissions
NCT04550052
Neoadjuvant FOLFOX Therapy With Short Course Radiation and Active Surveillance in Locally Advanced Rectal Cancer
NCT03781323
A Study of Cognitive Changes in Patients Receiving Brain Radiation
NCT04390906
Immunotherapy + Radiation in Resectable Soft Tissue Sarcoma
NCT03463408
Enhancing Brain Training With Virtual Reality
NCT03582579
Induction Chemotherapy for Locally Advanced Esophageal Cancer
NCT03110926
Vitamin D and Physical Activity on Bone Health
NCT01419730
Medical Cannabis Observational Study for Antiemetic Intervention in Chemotherapy
NCT07374939
Deaf CBT-TS to Reduce Suicide Risk
NCT07279363
Evaluation of a Patient-Centered Decision-Making Support Tool for Older Adults With Advanced Breast Cancer and Their Care Partners
NCT07599618
Efficacy of Methylene Blue Photodynamic Therapy for Treatment of Deep Tissue Abscesses
NCT06052956
Phase Resolved Functional Lung MRI and Oscillometry for the Observation of Healthy Lung Function
NCT07614685
Machine Learning Analysis of Two-photon Fluorescence Microscopy of Dermatologic Biopsies
NCT07682831
Ketamine-Assisted Psychotherapy for Treatment-Resistant Depression
NCT07247006
A Phase 2 Study of Methylene Blue Photodynamic Therapy for Treatment of Breast Abscesses
NCT07179003
Feasibility of 'Exercise for CAncer Patients and Healthy EAting Timeframes' .
NCT07529353
Sucrosomial Vs Intravenous Iron for Preoperative Anemia
NCT07287371
Investigating the Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on the Brain in People With Fibromyalgia
NCT07260864
Study of Platelet Rich Plasma Drops to Moderate Clinically Significant Dry Eye
NCT05121493
Dialectical Behavior Therapy for Adolescents With Fetal Alcohol Spectrum Disorders Feasibility Trial
NCT06747650
Daridorexant to Prevent Delirium After Heart Surgery
NCT06630390
Evaluation of Exotropia After Patching the Eye or After Prism Adaptation
NCT05242510
Cross-sectional Study of Vitamin B6 in Parkinson's Disease
NCT07430722
SOPHIE: Standardized Online Patient for Healthcare Interaction Education
NCT07409233
A Cultural Adaptation of the Caregiver TLC Psychoeducational Program to Support Latino Caregivers (CUIDANDO JUNTOS)
NCT06394388
Immunogenicity of RSV Vaccines in Residents of Long-Term Care Facilities (LTCF)
NCT06077149
Modifiers and Mechanisms of Loneliness Interventions
NCT05812989
Home-based tDCS for Prevention of Suicidal Ideation
NCT05280756
Study of the Families Moving Forward Website Behavioral Intervention for Teachers of Students With Fetal Alcohol Spectrum Disorder
NCT05986565
Treatment of Post-partum Depression Using an Behavioral Intervention Called ROSE (Reach Out, Stay Strong, Essentials for Mothers of Newborns) Delivered Using an Electronic App
NCT05518162
Investigation of Mohs Surgical Margins Using Two Photon Microscopy
NCT05814900
Study 1: Social Engage Coaching R61 Phase
NCT05745493
Yoga Versus Standard Care for Reducing Fatigue in Hispanic Cancer Survivors (YOCAS©®)
NCT05743491
Acceptability and Feasibility of Cognitive Behavioral Therapy for Treatment-Seeking (CBT-TS) With Deaf Individuals
NCT05520190
Deprescribing for Older Adults After Hospital Discharge in Home Health Care
NCT05630144
Feasibility Study of the My Health Coach App for Adults With FASD
NCT05604014
COACH-Cog Intervention Adaptation Focus Groups
NCT05775991
Latinos Kick Buts: Mobile Engagement and Cessation Support for Latinos Who Smoke
NCT05722132
Low-Carbohydrate and Plant-Based Dietary Effects on Vascular Health
NCT05414851
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 66 |
| Phase 2 | 81 |
| Phase 3 | 20 |
| Phase 4 | 34 |
Therapeutic Areas
What is open in the University of Rochester pipeline
94 recruiting of 636 indexed (15% open); 448 completed (70%).
Phase mix: 54 late (III/IV) vs 147 early (I/II) (early-phase heavy).
Top condition: Cancer (7 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Rochester: open-pipeline peers nationwide
Peers matched on 636 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
University of Rochester sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 636 trials (± recruiting share)
- US Department of Veterans Affairs · 632 trials · 0% recruiting
- University of Southern California · 617 trials · 16% recruiting
- Baylor College of Medicine · 616 trials · 15% recruiting
- University of California, Davis · 657 trials · 19% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Loma Linda University · 15% recruiting · 237 trials
- Dompé Farmaceutici S.p.A · 15% recruiting · 27 trials
- Vanderbilt-Ingram Cancer Center · 15% recruiting · 189 trials
- Brown University · 15% recruiting · 231 trials
Related
What to do with this University of Rochester page
636 registered trials is a research-attention snapshot, not an endorsement of University of Rochester or any single study.
- 94 of University of Rochester's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Cancer is the condition University of Rochester studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Rochester pipeline card: 636 registered trials from official public datasets.Report a data error.